The drug ReCell, introduced in 2005, was designed to treat burns by promoting healing and reducing scarring. Doctors now find that in addition to burns, it is also proving to be useful treating patients dealing with necrotizing fasciitis, commonly referred to as flesh-eating bacteria. This column also published in The Galveston County Daily News.